Nexentis Technologies NXTS
NASDAQ NXTS
$2.51 +2.00 (+392.16%)
At close: Nov 9, 2026 · 4:00 PM EST

Nexentis Technologies (NXTS) Income from Discontinued Operations (2024 - 2026)

Updated

Nexentis Technologies (NXTS) recorded Income from Discontinued Operations of -$605,000 in Q4 2025, compared with -$776,000 a year earlier.

Analysis

Nexentis Technologies (NXTS) Income from Discontinued Operations (2024 - 2026) Analysis & Trends

For FY2025, Nexentis Technologies reported Income from Discontinued Operations of -$561,000.

  • Across earlier years, Income from Discontinued Operations came in at -$1.03 million in FY2024.
  • Quarterly Income from Discontinued Operations has ranged from -$776,000 in Q4 2024 to $306,000 in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Nexentis Technologies 2.04 Mn -23.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 835,000.00
Dec 31, 2025 -605,000.00
Sep 30, 2025 306,000.00
Jun 30, 2025 -121,000.00
Dec 31, 2024 -776,000.00
Sep 30, 2024 -114,000.00
Jun 30, 2024 -21,000.00
API Access

Nexentis Technologies Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=NXTS&period=max&api_key=YOUR_API_KEY